Clinical trial
Characterizing Safety and Efficacy of Halo Hybrid Fractional Laser Treatments for Various Skin Conditions
NCT02693054 is registered in ClinicalTrials.gov with Sciton as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterizing Safety and Efficacy of Halo Hybrid Fractional Laser Treatments for Various Skin Conditions
- Lead sponsor
- Sciton
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- December 31, 2016
- Enrollment
- 34 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dyschromia, photodamaged skin